4.7 Review

Adipokine Signaling Pathways in Osteoarthritis

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2022.865370

关键词

adipokine; osteoarthritis; signaling pathway; cartilage; degeneration; obesity

资金

  1. National Natural Science Foundation of China [82102621]
  2. Foreign Cooperation Project of Science and Technology, Fujian Province [2020I0015]
  3. Joint Funds for the Innovation of Science and Technology, Fujian Province [2019Y9122]
  4. Fujian Provincial Health Technology Project [2019-ZQN-57]
  5. Startup Fund for Scientific Research, Fujian Medical University [2018QH1053]
  6. 2019-2020 Middle-aged Young Experts with Outstanding Contributions to Health in Fujian Province

向作者/读者索取更多资源

This review discusses the role of adipokines in obesity-induced osteoarthritis and highlights potential signaling pathways. Adipokines play important roles in regulating inflammation, matrix remodeling, and cell apoptosis. Pharmaceutical interventions targeting these pathways have shown promising results. However, further research is needed to understand the complexity and interactions of these pathways.
Osteoarthritis (OA) is a debilitating joint disease that affects millions of individuals. The pathogenesis of OA has not been fully elucidated. Obesity is a well-recognized risk factor for OA. Multiple studies have demonstrated adipokines play a key role in obesity-induced OA. Increasing evidence show that various adipokines may significantly affect the development or clinical course of OA by regulating the pro/anti-inflammatory and anabolic/catabolic balance, matrix remodeling, chondrocyte apoptosis and autophagy, and subchondral bone sclerosis. Several signaling pathways are involved but still have not been systematically investigated. In this article, we review the cellular and molecular mechanisms of adipokines in OA, and highlight the possible signaling pathways. The review suggested adipokines play important roles in obesity-induced OA, and exert downstream function via the activation of various signaling pathways. In addition, some pharmaceuticals targeting these pathways have been applied into ongoing clinical trials and showed encouraging results. However, these signaling pathways are complex and converge into a common network with each other. In the future work, more research is warranted to further investigate how this network works. Moreover, more high quality randomised controlled trials are needed in order to investigate the therapeutic effects of pharmaceuticals against these pathways for the treatment of OA. This review may help researchers to better understand the pathogenesis of OA, so as to provide new insight for future clinical practices and translational research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据